Literature DB >> 20221873

PON1 and oxidative stress in human sepsis and an animal model of sepsis.

Dragomir Draganov1, John Teiber, Catherine Watson, Charles Bisgaier, Jean Nemzek, Daniel Remick, Theodore Standiford, Bert La Du.   

Abstract

Sepsis is the leading cause of death in critically ill patients. The pathophysiological mechanisms implicated in the development of sepsis and organ failure are complex and involve activation of systemic inflammatory response and coagulation together with endothelial dysfunction. Oxidative stress is a major promoter and mediator of the systemic inflammatory response. Serum PON1 has been demonstrated in multiple clinical and animal studies to protect against oxidative stress, but also to undergo inactivation upon that condition. We found decreased plasma PON1 activity in patients with sepsis compared to healthy controls or critically ill patients without sepsis; furthermore, in sepsis patients PON1 activity was lower and remained lower in the course of sepsis in the non-survivors compared to the survivors. Plasma PON1 activity was positively correlated with high-density lipoprotein cholesterol and negatively correlated with markers of lipid peroxidation. In an experimental animal model of sepsis, murine cecal ligation and puncture, the time course of plasma PON1 activity was very similar to that found in sepsis patients. Persistently low PON1 activity in plasma was associated with lethal outcome in human and murine sepsis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20221873     DOI: 10.1007/978-1-60761-350-3_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  18 in total

1.  Evaluation of oxidative status in patients with Fasciola hepatica infection.

Authors:  H Karsen; M Sunnetcioglu; R M Ceylan; M Bayraktar; A Taskin; N Aksoy; R Erten
Journal:  Afr Health Sci       Date:  2011-08       Impact factor: 0.927

2.  HDL Cholesterol Efflux is Impaired in Older Patients with Early Sepsis: A Subanalysis of a Prospective Pilot Study.

Authors:  Faheem W Guirgis; Christiaan Leeuwenburgh; Victor Grijalva; Jennifer Bowman; Colleen Kalynych; Lyle Moldawer; Frederick A Moore; Srinivasa T Reddy
Journal:  Shock       Date:  2018-07       Impact factor: 3.454

3.  Paraoxonase 1 Activity and Survival in Sepsis Patients.

Authors:  Volkan İnal; Levent Yamanel; Gürhan Taşkın; Serkan Tapan; Bilgin Cömert
Journal:  Balkan Med J       Date:  2015-04-01       Impact factor: 2.021

4.  Increased inflammatory markers with altered antioxidant status persist after clinical recovery from severe sepsis: a correlation with low HDL cholesterol and albumin.

Authors:  Lucie Vavrova; Jana Rychlikova; Magdalena Mrackova; Olga Novakova; Ales Zak; Frantisek Novak
Journal:  Clin Exp Med       Date:  2015-09-28       Impact factor: 3.984

5.  Serum paraoxonase 1 activity in cats: analytical validation, reference intervals, and correlation with serum amyloid A and alpha-1-acid glycoprotein.

Authors:  Gabriele Rossi; Sara Meazzi; Alessia Giordano; Saverio Paltrinieri
Journal:  J Vet Diagn Invest       Date:  2020-08-17       Impact factor: 1.279

Review 6.  Paraoxonase 1 in neurological disorders.

Authors:  Teresita Menini; Alejandro Gugliucci
Journal:  Redox Rep       Date:  2013-11-12       Impact factor: 4.412

Review 7.  Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis.

Authors:  Ayman Samir Farid; Yoichiro Horii
Journal:  Lipids Health Dis       Date:  2012-07-23       Impact factor: 3.876

8.  Linezolid Exerts Greater Bacterial Clearance but No Modification of Host Lung Gene Expression Profiling: A Mouse MRSA Pneumonia Model.

Authors:  Jiwang Chen; Gang Feng; Yang Song; Juliane B Wardenburg; Simon Lin; Ichiro Inoshima; Michael Otto; Richard G Wunderink
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

9.  Relationship of oxidative stress in hepatitis B infection activity with HBV DNA and fibrosis.

Authors:  Fazilet Duygu; Hasan Karsen; Nurten Aksoy; Abdullah Taskin
Journal:  Ann Lab Med       Date:  2012-02-23       Impact factor: 3.464

10.  Anti-inflammatory mechanisms of apolipoprotein A-I mimetic peptide in acute respiratory distress syndrome secondary to sepsis.

Authors:  Oleg F Sharifov; Xin Xu; Amit Gaggar; William E Grizzle; Vinod K Mishra; Jaideep Honavar; Silvio H Litovsky; Mayakonda N Palgunachari; C Roger White; G M Anantharamaiah; Himanshu Gupta
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.